Gene: GP6

51206
BDPLT11|GPIV|GPVI
glycoprotein VI platelet
protein-coding
19q13.42
Ensembl:ENSG00000088053 MIM:605546 Vega:OTTHUMG00000159709 UniprotKB:Q9HCN6
NG_031963.2
PubMed|SNP Mapped
CD|ND
9   
5.962e-1 (AD)  5.803e-1 (ND)   (Frontal_Cortex)
2.509e-1 (AD)  1.470e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs1613662chr19:55025227 (GRCh38.p7)G>Acocaine dependenceSNV(Single Nucleotide Variation)
rs2304167chr19:55015713 (GRCh38.p7)C>Tcocaine dependenceSNV(Single Nucleotide Variation)
rs1654413chr19:55014991 (GRCh38.p7)A>Tcocaine dependenceSNV(Single Nucleotide Variation)
rs1671152chr19:55014977 (GRCh38.p7)T>Gcocaine dependenceSNV(Single Nucleotide Variation)
rs1671151chr19:55014526 (GRCh38.p7)G>Acocaine dependenceSNV(Single Nucleotide Variation)
rs1671150chr19:55014129 (GRCh38.p7)A>Gcocaine dependenceSNV(Single Nucleotide Variation)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg25818583chr19:55549801GP64.000e-9Smoking27651444
cg02462353chr19:55549799GP62.900e-8Smoking27651444

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
ZFR20.756
ITGA2B0.743
MYO15A0.741
RABL2A0.739
SRRM30.739
BRICD50.737
PTCH20.735
VTN0.728
SLC26A100.727
PKD10.724

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
YES1-0.408
SLC40A1-0.396
ASB4-0.374
TFPI2-0.37
C9orf135-0.369
REST-0.369
PHEX-0.368
CDCA7L-0.362
PABPC4L-0.359
NXT2-0.358

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
D001241AspirinGP6 gene polymorphism results in decreased susceptibility to Aspirin16493486
C006780bisphenol Abisphenol A results in decreased expression of GP6 mRNA25181051
D002104CadmiumCadmium results in decreased expression of GP6 mRNA24376830
D004041Dietary FatsDietary Fats results in increased expression of GP6 mRNA25016146
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GP6 mRNA25613284
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GP6 mRNA25613284
D014810Vitamin EVitamin E results in decreased expression of GP6 mRNA19244175

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0004888transmembrane signaling receptor activity-TAS10822077  
GO:0005515protein binding-IPI1715582  19940238  
GO:0005518collagen binding-TAS11027634  
GO:0038023signaling receptor activity-TAS11027634  
GO ID GO Term Qualifier Evidence PubMed
GO:0007167enzyme linked receptor protein signaling pathway-TAS9153205  
GO:0007596blood coagulation-TAS-  
GO:0030168platelet activation-NAS11027634  
GO:0030168platelet activation-TAS-  
GO:0050900leukocyte migration-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005886plasma membrane-TAS-  
GO:0005887integral component of plasma membrane-TAS10822077  
GO:0009986cell surface-HDA23382103  
GO:0070062extracellular exosome-HDA23533145  
GO:0097197tetraspanin-enriched microdomain-IDA18795891  
KEGG ID KEGG Term
hsa04512ECM-receptor interaction
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisTAS
R-HSA-114604GPVI-mediated activation cascadeTAS
R-HSA-202733Cell surface interactions at the vascular wallTAS
R-HSA-75892Platelet Adhesion to exposed collagenTAS
R-HSA-76002Platelet activation, signaling and aggregationTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
25147721Detection of human papillomavirus in chronic cervicitis, cervical adenocarcinoma, intraepithelial neoplasia and squamus cell carcinoma. (2014 May)Mirzaie-Kashani EJundishapur J Microbiol
16129653Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions. (2005 Nov)Campisi GOral Oncol
20695077Human papillomavirus as an independent predictor in oral squamous cell cancer. (2009 Sep)Zhao DInt J Oral Sci
19654578Differences in the risk of cervical cancer and human papillomavirus infection by education level. (2009 Sep 1)Franceschi SBr J Cancer
16476033H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia. (2006 Mar)Piscopo MOral Dis
15583544HPV DNA in clinically different variants of oral leukoplakia and lichen planus. (2004 Dec)Campisi GOral Surg Oral Med Oral Pathol Oral Radiol Endod
15288840Proliferative verrucous vs conventional leukoplakia: no significantly increased risk of HPV infection. (2004 Sep)Campisi GOral Oncol
15729691Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks. (2005 Jul 10)Lo Muzio LInt J Cancer
18164962High association of human papillomavirus infection with oral cancer: a case-control study. (2008 Feb)Anaya-Saavedra GArch Med Res